$LDOS stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $34,276,686 of trading volume.
It has been the 289th most-searched ticker on Quiver Quantitative over the last day, out of 11,418 total tickers searched.
Here is what we see in our data on $LDOS (you can track the company live on Quiver's $LDOS stock page):
$LDOS Insider Trading Activity
$LDOS insiders have traded $LDOS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $LDOS stock by insiders over the last 6 months:
- ELIZABETH A PORTER (Sector President) has made 0 purchases and 3 sales selling 6,000 shares for an estimated $1,119,765.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LDOS Hedge Fund Activity
We have seen 443 institutional investors add shares of $LDOS stock to their portfolio, and 454 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,976,156 shares (-76.3%) from their portfolio in Q4 2025, for an estimated $536,898,542
- CITADEL ADVISORS LLC removed 594,344 shares (-78.2%) from their portfolio in Q4 2025, for an estimated $107,219,657
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 573,098 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $108,292,598
- FMR LLC removed 537,364 shares (-14.6%) from their portfolio in Q4 2025, for an estimated $96,940,465
- PACER ADVISORS, INC. removed 504,599 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $91,029,659
- BLACKROCK, INC. removed 470,665 shares (-4.4%) from their portfolio in Q4 2025, for an estimated $84,907,966
- M&T BANK CORP added 391,784 shares (+2924.4%) to their portfolio in Q4 2025, for an estimated $70,677,833
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LDOS Government Contracts
We have seen $8,708,759,486 of award payments to $LDOS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FY26 FUNDING MEDICAL DISABILITY EXAMINATIONS: $754,312,385
- FY26 FUNDING MEDICAL DISABILITY EXAMINATIONS: $392,676,748
- FY25 Q3 EXAMS R2: $382,099,483
- FY26 FUNDING MEDICAL DISABILITY EXAMINATIONS: $348,691,285
- MODIFICATION TO UPDATE REVISE PWS AND ATTACHMENT AR.: $335,920,664
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$LDOS Analyst Ratings
Wall Street analysts have issued reports on $LDOS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/13/2026
- B of A Securities issued a "Buy" rating on 11/07/2025
- Argus Research issued a "Buy" rating on 09/24/2025
To track analyst ratings and price targets for $LDOS, check out Quiver Quantitative's $LDOS forecast page.
$LDOS Price Targets
Multiple analysts have issued price targets for $LDOS recently. We have seen 9 analysts offer price targets for $LDOS in the last 6 months, with a median target of $215.0.
Here are some recent targets:
- Jonathan Siegmann from Stifel set a target price of $205.0 on 02/18/2026
- Ken Herbert from RBC Capital set a target price of $215.0 on 02/18/2026
- Peter Arment from Baird set a target price of $195.0 on 02/18/2026
- Gavin Parsons from UBS set a target price of $204.0 on 01/15/2026
- John Godyn from Citigroup set a target price of $232.0 on 01/13/2026
- Mariana Perez from B of A Securities set a target price of $235.0 on 11/07/2025
- Tobey Sommer from Truist Securities set a target price of $220.0 on 11/05/2025
You can track data on $LDOS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
